Montserrat Rivero

2.9k total citations
36 papers, 648 citations indexed

About

Montserrat Rivero is a scholar working on Epidemiology, Hepatology and Genetics. According to data from OpenAlex, Montserrat Rivero has authored 36 papers receiving a total of 648 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 17 papers in Hepatology and 10 papers in Genetics. Recurrent topics in Montserrat Rivero's work include Liver Disease Diagnosis and Treatment (11 papers), Inflammatory Bowel Disease (10 papers) and Hepatitis B Virus Studies (8 papers). Montserrat Rivero is often cited by papers focused on Liver Disease Diagnosis and Treatment (11 papers), Inflammatory Bowel Disease (10 papers) and Hepatitis B Virus Studies (8 papers). Montserrat Rivero collaborates with scholars based in Spain, United States and Venezuela. Montserrat Rivero's co-authors include Javier Crespo, F. Pons‐Romero, Emilio Fábrega, Eloy Sánchez, Joaquín de la Peña, Fernando Casafont, Mercedes Vergara, José Luis Martín-Lorente, Enric Brullet and Beatriz Castro and has published in prestigious journals such as Hepatology, Scientific Reports and Journal of Hepatology.

In The Last Decade

Montserrat Rivero

31 papers receiving 626 citations

Peers

Montserrat Rivero
Ki Jun Han South Korea
Kâmil Özdil Türkiye
Jonas Weyler Belgium
Soo Hyung Ryu South Korea
Montserrat Rivero
Citations per year, relative to Montserrat Rivero Montserrat Rivero (= 1×) peers M. Koulentaki

Countries citing papers authored by Montserrat Rivero

Since Specialization
Citations

This map shows the geographic impact of Montserrat Rivero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Montserrat Rivero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Montserrat Rivero more than expected).

Fields of papers citing papers by Montserrat Rivero

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Montserrat Rivero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Montserrat Rivero. The network helps show where Montserrat Rivero may publish in the future.

Co-authorship network of co-authors of Montserrat Rivero

This figure shows the co-authorship network connecting the top 25 collaborators of Montserrat Rivero. A scholar is included among the top collaborators of Montserrat Rivero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Montserrat Rivero. Montserrat Rivero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pascual, Marta, Vicente González‐Quintanilla, Beatriz Castro, et al.. (2024). Differences in circulating alpha‐calcitonin gene–related peptide levels in inflammatory bowel disease and its relation to migraine comorbidity: A cross‐sectional study. Headache The Journal of Head and Face Pain. 64(7). 849–858. 2 indexed citations
2.
González‐Quintanilla, Vicente, Beatriz Castro, María José García, et al.. (2024). Unravelling the role of beta-CGRP in inflammatory bowel disease and its potential role in gastrointestinal homeostasis. BMC Gastroenterology. 24(1). 262–262. 5 indexed citations
3.
Pascual, Marta, Montserrat Rivero, María Toriello, et al.. (2022). Serum Calcitonin Gene-Related Peptide α and β Levels are Increased in COVID-19 Inpatients. Archives of Medical Research. 54(1). 56–63. 12 indexed citations
4.
García, María José, Marta Pascual, Álvaro Díaz‐González, et al.. (2020). Impact of immune-mediated diseases in inflammatory bowel disease and implications in therapeutic approach. Scientific Reports. 10(1). 10731–10731. 26 indexed citations
5.
Gutiérrez, Ana, Montserrat Rivero, María Dolores Martin‐Arranz, et al.. (2019). Perioperative management and early complications after intestinal resection with ileocolonic anastomosis in Crohn’s disease: analysis from the PRACTICROHN study. Gastroenterology report. 7(3). 168–175. 12 indexed citations
6.
Chaparro, María, José Luis Cabriada, María José Casanova, et al.. (2018). P423 Epidemiology, diagnostic work-up and pharmacological requirements of inflammatory bowel disease (IBD) in Spain: Results from the nationwide EpidemIBD study of GETECCU. Journal of Crohn s and Colitis. 12(supplement_1). S318–S319.
7.
Fernández‐Salazar, Luis, Fernándo Muñoz, Jésus Barrio, et al.. (2015). Infliximab in ulcerative colitis: real-life analysis of factors predicting treatment discontinuation due to lack of response or colectomy: ECIA (ACAD Colitis and Infliximab Study). Scandinavian Journal of Gastroenterology. 51(2). 186–195. 4 indexed citations
8.
Arias, M., Michael Mähler, Beatriz Castro, et al.. (2013). Presence of Anti-proteinase 3 Antineutrophil Cytoplasmic Antibodies (Anti-PR3 ANCA) as Serologic Markers in Inflammatory Bowel Disease. Clinical Reviews in Allergy & Immunology. 45(1). 109–116. 57 indexed citations
9.
Arias, M., Beatriz Castro, Montserrat Rivero, & Javier Crespo. (2012). Epidemiology of intrafamilial inflammatory bowel disease throughout Europe.. PubMed. 25(3). 188–192. 3 indexed citations
10.
Peña, Joaquín de la, et al.. (2006). Comparación de las estenosis esofágicas producidas por escleroterapia o ligadura de varices. Gastroenterología y Hepatología. 29(9). 523–527. 1 indexed citations
11.
Mazuecos, Auxiliadora, et al.. (2005). Treatment With Adefovir Dipivoxil in a Renal Transplant Patient With Renal Insufficiency and Lamivudine-Resistant Hepatitis B Infection. Transplantation Proceedings. 37(3). 1462–1463. 12 indexed citations
12.
Peña, Joaquín de la, Enric Brullet, Eloy Sánchez, et al.. (2005). Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding. Hepatology. 41(3). 572–578. 145 indexed citations
13.
Rivero, Montserrat, et al.. (2003). Frecuencia de especies de Candida aisladas en pacientes embarazadas con vulvovaginitis.. Revista de la Sociedad Venezolana de Microbiología. 23(2). 148–152. 9 indexed citations
14.
Rivero, Montserrat, Javier Crespo, Emilio Fábrega, et al.. (2002). Apoptosis mediated by the Fas system in the fulminant hepatitis by hepatitis B virus. Journal of Viral Hepatitis. 9(2). 107–113. 51 indexed citations
15.
Rivero, Montserrat, et al.. (2002). Involvement of the Fas system in liver allograft rejection. The American Journal of Gastroenterology. 97(6). 1501–1506. 26 indexed citations
16.
Crespo, Javier, Montserrat Rivero, Emilio Fábrega, et al.. (2002). Plasma Leptin and TNF-α Levels in Chronic Hepatitis C Patients and Their Relationship to Hepatic Fibrosis. Digestive Diseases and Sciences. 47(7). 1604–1610. 70 indexed citations
17.
Fábrega, Emilio, Javier Crespo, Montserrat Rivero, et al.. (2001). Dendroaspis natriuretic peptide in hepatic cirrhosis. The American Journal of Gastroenterology. 96(9). 2724–2729. 3 indexed citations
18.
Crespo, Javier, Montserrat Rivero, Marta Mayorga, et al.. (2000). Involvement of the fas system in hepatitis C virus recurrence after liver transplantation. Liver Transplantation. 6(5). 562–569. 14 indexed citations
19.
Rivero, Montserrat, et al.. (1999). Variceal ligation compared with endoscopic sclerotherapy for variceal hemorrhage: prospective randomized trial. Gastrointestinal Endoscopy. 49(4). 417–423. 82 indexed citations
20.
Crespo, Javier, Emilio Fábrega, Fernando Casafont, et al.. (1999). Severe clinical course of de novo hepatitis B infection after liver transplantation. Liver Transplantation and Surgery. 5(3). 175–183. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026